Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).

  • FEAnalytics.com
  • FEInvest.net
  • FETransmission.com
  • Investegate.co.uk
  • Trustnet.hk
  • Trustnetoffshore.com
  • Trustnetmiddleeast.com

For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.

WHAT INFORMATION DO WE COLLECT ABOUT YOU?

We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.

COOKIES

In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.

HOW WE USE INFORMATION

We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.

ACCESS TO YOUR INFORMATION AND CORRECTION

We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.

WHERE WE STORE YOUR PERSONAL DATA

The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.

CHANGES TO OUR PRIVACY POLICY

Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.

OTHER WEBSITES

Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.

CONTACT

If you want more information or have any questions or comments relating to our privacy policy please email publishing@financialexpress.net in the first instance.

 Information  X 
Enter a valid email address

Marlborough Stirling (MAS)

  Print      Mail a friend

Friday 20 April, 2001

Marlborough Stirling

Holding in Company

Marlborough Stirling PLC
19 April 2001


                  DEALINGS BY SUBSTANTIAL SHAREHOLDERS


1)   NAME OF COMPANY

     MARLBOROUGH STIRLING PLC

2)   NAME OF SHAREHOLDER HAVING A MAJOR INTEREST

     3i GROUP PLC

3)   Please state whether notification indicates that it is in respect of 
     holding of the Shareholder named in 2 above or in respect of a 
     non-beneficial interest or in the case of an individual holder if it is a
     holding of that person's spouse or children under the age of 18

     HOLDING OF SHAREHOLDER IN BOX 2

4)   Name of the registered holder(s) and, if more than one holder, the 
     number of shares held by each of them.

     3i GROUP PLC

5)   Number of shares/amount of stock acquired.



6)   ( N/A %) of issued Class

7)   Number of shares/amount of stock disposed

     10,381,371

8)   (5.8 %) of issued Class

9)   Class of security

     ORDINARY SHARES of 1pence EACH

10)  Date of transaction

     9 APRIL 2001

11)  Date company informed

     11 APRIL 2001

12)  Total holding following this notification

     20,682,599
              
13)  Total percentage holding of issued class following this notification

     11.5%

14)  Any additional information



15)  Name of contact and telephone number for queries

     SIMON FIELDER - 020 7809 1020

16)  Name and signature of authorised company official responsible for 
     making this notification

     Date of Notification ..19th APRIL 2001



                  DEALINGS BY SUBSTANTIAL SHAREHOLDERS


1)   NAME OF COMPANY

     MARLBOROUGH STIRLING PLC

2)   NAME OF SHAREHOLDER HAVING A MAJOR INTEREST

     UBS AG

3)   Please state whether notification indicates that it is in respect of 
     holding of the Shareholder named in 2 above or in respect of a 
     non-beneficial interest or in the case of an individual holder if it is a
     holding of that person's spouse or children under the age of 18

     SEE SCHEDULE BELOW

4)   Name of the registered holder(s) and, if more than one holder, the 
     number of shares held by each of them.

     SEE SCHEDULE BELOW

5)   Number of shares/amount of stock acquired.

     SEE SCHEDULE BELOW

6)   (SEE SCHEDULE BELOW %) of issued Class

7)   Number of shares/amount of stock disposed

     SEE SCHEDULE BELOW

8)   (SEE SCHEDULE BELOW %) of issued Class

9)   Class of security

     ORDINARY SHARES of 1pence EACH

10)  Date of transaction

     9 APRIL 2001

11)  Date company informed

     10 APRIL 2001

12)  Total holding following this notification

     SEE SCHEDULE BELOW
              
13)  Total percentage holding of issued class following this notification

     SEE SCHEDULE BELOW

14)  Any additional information



15)  Name of contact and telephone number for queries

     SIMON FIELDER - 020 7809 1020

16)  Name and signature of authorised company official responsible for 
     making this notification

     Date of Notification ..19th APRIL 2001



Annexure to Schedule 10 declaration - Marlborough Stirling plc - UBS AG

1. As at midnight on 9 April 2001 UBS AG was interested for the purposes of Part
VI Companies Act 1985 (the Act) in 12,212,808 ordinary shares of 1 pence each
(relevant shares) in the capital of the company (ordinary shares) representing
6.9% of the issued ordinary share capital of the company

UBS AG was interested in 11,155,308 of these ordinary shares by virtue of
section 208(5) of the Act as a result of the possibility of there being physical
delivery of such ordinary shares at the maturity dates of the financial futures
contracts referred to under 'Shareholder Arrangements' in Part II of the price
range listing particulars of the company published on 19 March 2001 (the price
range listing particulars).

As at midnight on 9 April 2001

(a)  3i Group plc (or its nominee) was the registered holder of 1,057,500 of the
     relevant shares;

(b)  Christopher Herbert Ryland was the registered holder of 1,844,602 of the   
     relevant shares;

(c)  Grant Thornton Stonehage Limited, James Samuel Colclough and Edward James  
     Noel as trustees of the Huw Evans Cayman Islands Life Interest Settlement  
     were the registered holders of 3,611,566 of the relevant shares;

(d)  David Robert Gales and Jonathan Francis Kirby as executors and trustees of 
     The Christine Gales Family Legacy Will Trust were the registered holders of
     3,466,566 of the relevant shares.

(e)  David Robert Gales and Jonathan Francis Kirby as trustees for the Mr D. R. 
     Gales' Children's Settlement were the registered holders of 165,000 of the 
     relevant shares;

(f)  Grant Thornton Stonehage Limited and Clarendon Nominees Limited as         
     trustees of The Christopher Ryland (No.1) Discretionary Settlement
     were the registered holders of 883,482 of the relevant shares;

(g)  Grant Thornton Stonehage Limited and Clarendon Nominees Limited as         
     trustees of The Christopher Ryland (No.2) Discretionary Settlement was
     and are the registered holders of 883,482 of the relevant shares;

(h)  James Mark Deane, Michael Bruce Warburton and Martin Mitchell Davis
     as trustees of the J.M.. Deane Interests in Possession Settlement were
     the registered holders of 151,860 of the relevant shares;

(i)  James Mark Deane, Michael Bruce Warburton and Martin Mitchell Davis as     
     trustees of the J.M. Deane's Children's Settlement were the registered     
     holders of 168,750 of the relevant shares.

2.  In addition to the above UBS AG, acting through its business group UBS      
    Warburg (UBS Warburg), entered into a sponsorship and underwriting agreement
    dated 19 March 2001 with the Company, the Directors (as defined therein),   
    the Connected Trustees (as defined therein), the Selling Shareholders (as   
    defined therein), UBS Warburg Limited and HSBC Investment Bank plc (HSBC),  
    as amended and supplemented by a supplemental agreement dated 4 April 2001
    (together, the Underwriting Agreement) pursuant to which UBS Warburg agreed,
    amongst other things, to:

     (a) on the terms and subject to the conditions of the Underwriting
         Agreement, purchase 10,381,371 ordinary shares from 3i Group plc       
         representing 5.8 % of the issued ordinary share capital of
         the company, and to the extent that it was able to, sell such
         ordinary shares to purchasers procured by it in the Institutional
         Offer (as defined in the price range listing particulars); and

     (b) on and subject to the terms and conditions of the stock lending
         agreements referred to under 'Shareholder Arrangements' in
         Part II of the price range listing particulars, borrow, conditional
         upon Admission (as defined in the price range listing particulars),    
         11,155,308 ordinary shares from the Stock Lending Parties (as defined  
         in the price range listing particulars) representing 6.3% of the       
         issued ordinary share capital of the company and, to the extent that   
         it was able to, sell such ordinary shares to purchasers procured
         by it in the Institutional Offer; and

UBS Warburg entered into a stock lending agreement on 4 April 2001 with Abacus
Corporate Trustee Limited as trustee of the Marlborough Stirling plc Employee 
Share Ownership Trust No.2 (the Trustee) pursuant to which UBS Warburg had the 
right, conditional upon Admission, to borrow up to 7,050,000 ordinary shares
representing 4.0% of the issued ordinary share capital of the company.

3.  As a consequence of the above matters prior to midnight on 9 April 2001, 
    UBS AG was interested for the purposes of the Act in:

   (a) 10,381,371 ordinary shares as a result of its having purchased
       such shares from 3i Group plc at Admission but, as a result of
       these 10,381,371 ordinary shares having been transferred shortly after   
       Admission to purchasers procured by UBS Warburg, UBS AG has ceased to    
       have an interest in such shares;

   (b) 11,155,308 ordinary share as a result of it having borrowed such shares  
       from the Stock Lending Parties at Admission but as a result of these     
       11,155,308 ordinary shares having been transferred, shortly after        
       Admission, to purchasers procured by UBS Warburg, UBS AG has ceased to   
       have an interest in such shares;

   (c) 7,050,000 ordinary shares as a result of it having borrowed such shares  
       from the Trustee at Admission but, as a result of these 7,050,000        
       ordinary shares having been transferred, shortly after Admission, to     
       purchasers procured by UBS Warburg, UBS AG has ceased to have an interest
       in such shares;

4.  as at midnight on 9 April 2001 and as at the date hereof

    (a) 3i Group plc (or its nominee) was the registered holder of the          
        10,381,371 ordinary shares referred to in paragraph (3)(a) and,         
        following their purchase by UBS AG (as referred to in paragraph 3), 
        UBS AG (or its nominee) became the registered owner of such shares;

    (b) in respect of the ordinary shares referred to in paragraph 3(b)

        (i) Huw Dewi Evans (or his nominee) was the registered holder of        
            2,457,470 of such shares;

       (ii) David Robert Gales (or his nominee) was the registered holder of    
            2,634,970 of such shares;

      (iii) James Mark Deane (or his nominee) was the registered holder of      
            320,610 of such shares

       (iv) David Robert Gales, Christopher Herbert Ryland and Huw Dewi Evans as
            trustees of the J.M. Deane Ryland Family Settlement (or their       
            nominee) were the registered holders of 4,588,162 of such shares;   
            and

        (v) Huw Evans, David Robert Gales and Christopher Ryland as trustees    
            of the J.M. Deane Evans Family Settlement (or their nominee) were   
            the registered holders of 1,154,096 of such shares and, following   
            the completion of the borrowing referred to in paragraph 3(b) UBS   
            AG (or its nominee) became the registered holder of such ordinary   
            shares; and

    (c) Abacus Corporate Trustee Limited was the registered holder of the       
        7,050,000 ordinary shares referred to in paragraph 3(c) and, following  
        the completion of the borrowing referred to in paragraph 3 (c) UBS AG   
        (or its nominee) became the registered holder of such ordinary shares.

None of the ordinary shares referred to in paragraph 3 were shares in which UBS
AG was interested by virtue of section 208 (5) of the Act.